BFM
ABEO icon

Boothbay Fund Management’s Abeona Therapeutics ABEO Stock Holding History

Boothbay Fund Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,816
Closed -$94.1K – 1911
2025
Q3 		$94.1K Sell
17,816
-2,770
-13% -$17.6K ﹤0.01% 1735
2025
Q2 		$117K Sell
20,586
-197,820
-91% -$1.13M ﹤0.01% 1299
2025
Q1 		$1.04M Sell
218,406
-59,179
-21% -$322K 0.03% 613
2024
Q4 		$1.55M Buy
277,585
+56,048
+25% +$345K 0.04% 513
2024
Q3 		$1.4M Sell
221,537
-12,295
-5% -$64.2K 0.03% 644
2024
Q2 		$991K Sell
233,832
-36,508
-14% -$186K 0.02% 723
2024
Q1 		$1.96M Buy
270,340
+110,080
+69% +$698K 0.04% 520
2023
Q4 		$803K Buy
+160,260
New +$705K 0.02% 803
2021
Q3 		– Sell
-991
Closed -$39K – 1856
2021
Q2 		$39K Buy
+991
New +$40.4K ﹤0.01% 1777
2020
Q1 		– Sell
-400
Closed -$33K – 820
2019
Q4 		$33K Buy
+400
New +$28.2K ﹤0.01% 812

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boothbay Fund Management's ABEO Position: Q4 2025 in Review

Boothbay Fund Management sold out of Abeona Therapeutics (ABEO) in Q4 2025, closing a stake of 17,816 shares — an estimated $94.1K sold.

Boothbay Fund Management first reported a position in ABEO in Q4 2019 and held it in 10 quarters. The position peaked at $1.96M in Q1 2024. 104 funds tracked by Wall St. Rank hold ABEO as of Q4 2025.

  • Boothbay Fund Management reported no remaining Abeona Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 17,816 Abeona Therapeutics shares in Q4 2025, an estimated $94.1K.
  • Boothbay Fund Management first reported a position in Abeona Therapeutics in Q4 2019 and held it in 10 quarters.
  • Boothbay Fund Management's Abeona Therapeutics position peaked at $1.96M in Q1 2024.
  • 104 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.